TickerFacts.

Sonoma Pharmaceuticals, Inc. (SNOA): Gross Profit

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2016-03-31, 2020-03-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$7.42M
Year ended 2026-03-31
$8.53M
Trailing 12 months to 2026-06-30
+18.3%
3-year compound annual growth
+2.5%
5-year compound annual growth
$10.74M2011-03-31: $6.14M2012-03-31: $8.71M2013-03-31: $10.74M2014-03-31: $8.40M2015-03-31: $7.29M2016-03-31: $2.65M2017-03-31: $5.67M2018-03-31: $7.31M2019-03-31: $8.88M2020-03-31: $8.12M2021-03-31: $6.56M2022-03-31: $3.99M2023-03-31: $4.48M2024-03-31: $4.75M2025-03-31: $5.46M2026-03-31: $7.42M$7.42M
2011-03-31 Gross Profit (USD) 2026-03-31
Period endedGross ProfitChange YoYSource filing
2026-03-31$7.42M+35.7%2026-06-16, From 2025-04-01
2025-03-31$5.46M+15.2%2026-06-16, From 2024-04-01
2024-03-31$4.75M+6.0%2025-06-17, From 2023-04-01
2023-03-31$4.48M+12.1%2024-06-17, From 2022-04-01
2022-03-31$3.99M-39.1%2023-06-21, From 2021-04-01
2021-03-31$6.56M-19.2%2022-07-13, From 2020-04-01
2020-03-31$8.12Mn/c2021-07-14, From 2019-04-01
2019-03-31$8.88M+21.5%2020-07-10, From 2018-04-01
2018-03-31$7.31M+29.0%2019-07-01, From 2017-04-01
2017-03-31$5.67M+114.0%2018-06-26, From 2016-04-01
2016-03-31$2.65Mn/c2017-06-28, From 2015-04-01
2015-03-31$7.29M-13.2%2016-06-21, From 2014-04-01
2014-03-31$8.40M-21.8%2015-06-16, From 2013-04-01
2013-03-31$10.74M+23.3%2014-06-30, From 2012-04-01
2012-03-31$8.71M+41.9%2013-06-25, From 2011-04-01
2011-03-31$6.14Mn/a2012-06-21, From 2010-04-01

Gross Profit at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31$7.42M+35.7%
Spectral AI, Inc. (MDAI)2025-12-31$8.93M-32.8%
Nephros Inc (NEPH)2025-12-31$11.62M+33.3%
Vivos Therapeutics, Inc. (VVOS)2025-12-31$10.54M+16.9%
DarioHealth Corp. (DRIO)2025-12-31$12.66M-4.5%
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31$18.88M-42.2%
Profound Medical Corp. (PROF)2025-12-31$11.39M+61.9%
Biotricity Inc. (BTCY)2026-03-31$12.95M+22.6%
Allurion Technologies, Inc. (ALUR)2025-12-31$9.57M-55.5%

Compare SNOA, MDAI, NEPH, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗